We are committed to developing safe and effective products for the treatment and control of CNS disorders
MG01CI is under development for effective treatment of ADHD symptoms
MG01CI is well tolerated in clinical trials of adults with ADHD
MG01CI is formulated to provide both rapid and sustained clinical effects
MG01CI is developed as a non-scheduled drug candidate for ADHD
